Dr. Annaelle Devergnas' research lab at Emory University focuses on understanding the propagation of temporal lobe seizures through the basal ganglia in order to develop better treatment options for epilepsy. Researchers study how different patterns of seizure onset influence the way these seizures travel through brain circuits. The lab uses a non-human primate model to explore the dopaminergic system and its role in seizure control, aiming to uncover insights that could lead to individualized therapies for patients suffering from intractable epilepsy.

Dr. Stella M Papa's lab at Emory University focuses on understanding and treating Parkinson's disease (PD), a progressive neurological disorder characterized by the loss of dopamine-producing cells. The lab studies the changes in dopamine signaling and striatal neuron function that occur in PD, with the goal of developing new therapeutic strategies. They utilize advanced animal models and gene therapy techniques to target specific aspects of the disease, hoping to enhance treatment outcomes and improve patients' quality of life.

Dr. Erik C.B. Johnson's research lab at Emory University focuses on understanding Alzheimer's disease, particularly the less commonly studied early-onset cases that affect individuals under 65. By comparing the biological changes in early-onset Alzheimer's with later-onset and genetically inherited forms of the disease, the lab aims to uncover specific protein alterations that characterize these conditions. The ultimate goal is to improve diagnostic tools and treatment strategies for all forms of Alzheimer's disease, tailoring them for younger patients.